-- 路透社引述多位分析師和煉油業人士的消息報道,由於亞洲原油進口量觸及十年來的最低點,亞洲煉油商的煉油量預計將大幅下降。 報告稱,伊朗的軍事衝突迫使煉油商加工輕質原油,同時將柴油和航空煤油的日產量削減多達100萬桶,導致這些關鍵市場的供應顯著緊張。 路透社引述Kpler的數據稱,亞洲4月份原油進口量預計將年減22%,至每日2,040萬桶,為2016年以來的最低水準。 儘管該地區各國積極收購滯留在海上的受制裁的俄羅斯和伊朗原油,但進口量仍下滑。 顧問公司Energy Aspects預計,亞洲原油加工量4月將降至2,840萬桶/日,5月將降至2,870萬桶/日,而3月為3,040萬桶/日。 FGE NexantECA高級石油分析師Amir Abu Hassan告訴路透社,4月的減產幅度將最大,因為替代供應將從下週開始陸續到位。 根據研究公司Horizon Insight的數據顯示,中國已限制燃料出口以保障國內供應,導致煉油廠加工量下降。 4月中旬,煉油廠加工量為1,340萬桶/日,而2月份(衝突爆發前一週)的加工量為1,540萬桶/日。 該公司還指出,這些減產主要發生在中國的國有煉油廠,這些煉油廠提高了運輸燃料的產量,從而減少了用於石化產品的石腦油產量。 根據FGE的哈桑向路透社透露,預計韓國和日本的煉油廠開工率將在4月下旬至5月初降至65%,此前兩國的開工率在70%至80%之間;而新加坡的開工率已從平均70%降至50%以下。 同時,據路透社引述Rystad Energy分析師尼廷·普拉卡什的話報道,自2月以來,印度原油加工量已下降13%,至500萬桶/日。 Vortexa向路透社分享的數據顯示,由於霍爾木茲海峽關閉,約有1,200萬桶原油無法運往亞洲,其中800萬桶為中等密度、高硫含量的原油,通常用於提高柴油產量。 煉油商此後轉而使用來自美國的較輕質西德克薩斯中質原油(WTI)和中等含硫量的Mars原油,以及來自哈薩克和西非的類似原油,這些原油通常用於提高汽油和石腦油的產量。因此,這些地區正面臨柴油和航空煤油等中間餾分油的大量流失。 (市場動態新聞來自與全球市場專業人士的對話。這些資訊據信來自可靠來源,但可能包含傳聞和推測。準確性無法保證。)
Related Articles
Morgan Stanley Downgrades AES to Equalweight From Overweight, Adjusts Price Target to $15 From $23
AES (AES) has an average rating of hold and mean price target of $15.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Compass Therapeutics Tovecimig Study Falls Short on Overall Survival Endpoint in Biliary Tract Cancer; Shares Fall Pre-Bell
Compass Therapeutics (CMPX) reported that its experimental drug tovecimig did not meet the overall survival secondary endpoint in a phase 2/3 study in patients with advanced biliary tract cancer, the company said Monday.Shares of the company fell more than 63% in recent pre-bell activity Monday.The company said that tovecimig plus paclitaxel did not show a statistically significant overall survival benefit versus chemotherapy alone, largely due to high crossover from the control arm and prolonged survival after switching to the drug.However, the study met other key endpoints, including statistically significant improvements in progression-free survival and overall response rate versus paclitaxel alone.Compass Therapeutics plans to meet with the US Food and Drug Administration to discuss the results ahead of a planned biologics license application submission, it added.Price: $1.91, Change: $-3.11, Percent Change: -63.35%
Gold Eases Early Even as the Dollar Falls Ahead of This Week's U.S. Interest Rate Decision
Gold prices eased early on Monday, remaining rangebound even as the dollar fell ahead of the Wednesday interest-rate announcement from the Federal Reserve.Gold for June delivery was last seen down US$26.50 to US$4,714.40 per ounce, remaining within the US$200 range it has been stuck in since the start of the war on Iran, as high oil prices raise concerns over higher inflation and threaten to boost interest rates.The Federal Open Market Committee (FOMC) will make its latest interest-rate decision at the Wednesday afternoon end to its two-day meeting. The CME FedWatch Tool sees a 100% probability the group will leave rates unchanged."Gold remains stuck in neutral within a broad USD 200 range around USD 4,750, with most intraday price action dictated by energy prices and the ebb and flow of headlines from the White House and the Middle East. The FOMC is widely expected to leave rates unchanged on Wednesday," Saxo Bank noted.The dollar was lower early, with the ICE dollar index last seen down 0.28 points to 98.26. Treasury yields rose, with the yield on the two-year note up 1.0 basis points to 3.801%, while the 10-year note was paying 4.321%, up 1.3 points.